Company Overview

Update
Headquarters:
Aurora, CO
Funding:
$7.20M
Categories:
Biotechnology

ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.

Description

Update

ARCA biopharma, Inc. is a Colorado-based biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases.

ARCA’s principal focus is to develop personalized therapies for the treatment of cardiovascular disease through the use of genetics. The Company’s business focus combines expertise in cardiovascular pathophysiology, molecular genetics and clinical development.

Current Team (3)

Update

Funding Rounds (6) - $7.20M

Update
  • $1.30M

    Investors Unknown
    Jun 17, 2013 -Unknown
  • $250k

    Investors Unknown
    Dec 28, 2012 -Unknown
  • $325k

    Investors Unknown
    Oct 31, 2012 -Unknown
  • $4.50M

    Investors Unknown
    Jan 5, 2012 -Unknown

Offices/Locations (1)

Update
  • Office

    12635 E. Montview Blvd

    Suite 218

    Aurora, CO 80045

    USA

Images (1)

Update
  • E515b4e0018224d25ae6318bb8cf6b7e